首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
HCV COMBINATION THERAPY
摘要
The present invention relates to the treatment of hepatitis C (HCV) infection by the combination treatment with a miR-122 inhibitor and a HCV NS3/4A protease inhibitor.
申请公布号
EP2723863(A1)
申请公布日期
2014.04.30
申请号
EP20120730499
申请日期
2012.06.25
申请人
STELLA APS
发明人
HODGES, MICHAEL
分类号
C12N15/113;A61K31/454;A61K31/497;A61K31/7056;A61K31/7115;A61K31/712;A61K31/7125;A61P31/14
主分类号
C12N15/113
代理机构
代理人
主权项
地址
您可能感兴趣的专利
FLOATING VESSELS DRIVEN BY COMPRESSED AIR
SUPPORT AND CATALYST
STEREOREGULAR POLYMERIZATION OF ALPHA-OLEFINS
WARNING SYSTEMS FOR VEHICLES
AN AUTOMATIC COIN DELIVERY MACHINE
REDUCING POLYMER ADSORPTION IN SECONDARY OIL RECOVERY OPERATIONS
ELECTRIC TOASTER
EXHAUST GAS MANIFOLD
CONTINUOUS CASTING FOR DECORATIVE ARCHITECTURAL PANELS
FASTENER ATTACHMENT SYSTEMS
QUANTITY LEVEL GAUGE
WARNING SIGNAL RELAY AND SYSTEM
STETHOSCOPES
TELEPHONE SYSTEM
VALVE FOR LIQUID STORAGE VESSEL
METAL-WOOD FURNITURE
SULFUR RECOVERY SYSTEM
ALPHA-CYANABENZYL CYCLOPROPANECARBOXYLATED
FREQUENCY SUBTRACTORS
PRESSURE SENSITIVE HYDROPHONE